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Most of the airways of the human lung are lined by an epithelium
made up of ciliated and secretory luminal cells and undifferentiated
basal progenitor cells. The integrity of this epithelium and its ability
to act as a selective barrier are critical for normal lung function. In
other epithelia, there is evidence that transcription factors of the
evolutionarily conserved grainyheadlike (GRHL) family play key
roles in coordinating multiple cellular processes required for epithe-
lial morphogenesis, differentiation, remodeling, and repair. How-
ever, only a few target genes have been identified, and little is
known about GRHL function in the adult lung. Here we focus
on the role of GRHL2 in primary human bronchial epithelial cells,
both as undifferentiated progenitors and as they differentiate in
air–liquid interface culture into an organized mucociliary epithe-
lium with transepithelial resistance. Using a dominant-negative
protein or shRNA to inhibit GRHL2, we follow changes in epithelial
phenotype and gene transcription using RNA sequencing or micro-
array analysis. We identify several hundreds of genes that are
directly or indirectly regulated by GRHL2 in both undifferenti-
ated cells and air–liquid interface cultures. Using ChIP sequencing
to map sites of GRHL2 binding in the basal cells, we identify 7,687
potential primary targets and confirm that GRHL2 binding is
strongly enriched near GRHL2-regulated genes. Taken together,
the results support the hypothesis that GRHL2 plays a key role in
regulating many physiological functions of human airway epi-
thelium, including those involving cell morphogenesis, adhesion,
and motility.
The lung is composed of a highly branched, tree-like system oftubes ending in millions of alveoli for gas exchange. Most
of the conducting airways of the human lung are lined by an
epithelium made up of ciliated and secretory luminal cells and
undifferentiated basal progenitors (1, 2). This layer fulfills many
critical physiological functions, including mucociliary clearance
and innate host defense, and provides a barrier against pathogens
and allergens. The luminal cells are highly polarized, and their
lateral membranes contain specialized junctional domains that
mediate adhesion and the selective transcellular passage of ions,
molecules, and immune cells (3). Junctional complexes are con-
nected to the cytoskeleton and form part of an integrated system
maintaining epithelial integrity. Many of the components of this
system in the human lung are evolutionarily conserved and
function in other tubular systems (4), but we are still far from a
complete “systems biology” of the airway epithelium.
There are many reasons why such a goal is clinically relevant.
Defects in airway barrier function may increase susceptibility to
infection and inflammation, and underlie some aspects of dis-
orders such as asthma and chronic obstructive pulmonary disease
(5–7). There is also evidence that defects in the ability of basal
cells to regenerate an intact epithelium after damage promote
airway fibrosis (8). One way to uncover a gene regulatory network
governing the integrity of the airway epithelium is to identify key
regulators governing multiple downstream targets. Candidates
for this role include members of the conserved grainyheadlike
(GRHL) family of transcription factors. These are known to
control many aspects of epithelial behavior, including cell po-
larity, motility, morphogenesis, transcellular transport, lipid me-
tabolism, differentiation, and wound healing in multiple tissues
and species from Drosophila to human (9–14). In the embryonic
mouse lung, Grhl1–3 genes exhibit differential spatiotemporal
patterns of expression in the epithelium (15, 16). Recent analysis
of Grhl2 mutants, which die around embryonic day 11.5 from
neural tube closure defects, indicates that the gene plays a role in
lung branching morphogenesis (17). In addition, recent studies
with mouse lung alveolar-like cell lines in culture strongly sup-
port a role for Grhl2 in cell adhesion, motility, and junction
formation and identify a number of likely primary targets (16).
However, there has been no systematic study of GRHL proteins
in primary human bronchial epithelial (HBE) cells or genome-
wide analysis of their potential regulatory sites.
Here we show that GRHL genes are differentially expressed in
human airways and HBE cells differentiating into a mucociliary
epithelium (18). Using a dominant-negative mutant protein and
shRNA, we demonstrate that GRHL2 is required for the es-
tablishment and maintenance of epithelial barrier function and
regulates several hundreds of genes in basal and differentiated
cells. ChIP-seq (sequencing) experiments identify several thou-
sand potential primary targets in basal cells and confirm that
GRHL2 binding is strongly enriched near GRHL2-regulated
genes. Taken together, our results provide evidence that GRHL2
is a critical component of the gene regulatory network of human
airway epithelium.
Results
GRHL Protein Expression in Human Airways and HBE Cells in Culture.
In the normal human lung, immunohistochemistry (IHC) of sec-
tions of small and large airways shows GRHL2 in the nuclei of
both luminal and p63+ KRT5+ basal cells. By contrast, GRHL1
is expressed predominantly in MUC5AC+ goblet cells and
GRHL3 in acetylated tubulin+ ciliated cells (Fig. 1 A–E).
The in vitro culture of primary HBE cells presents a convenient
method for testing the function of GRHL proteins in airway
epithelium. When cultured in plastic dishes submerged in
growth medium, all cells remain undifferentiated and express
the basal markers p63 and KRT5. Even when confluent, they
Author contributions: X.G., C.M.V., S.H.R., T.E.R., and B.L.M.H. designed research; X.G., C.M.V.,
F.P., K.M.N., and Y.X. performed research; X.G., C.M.V., T.E.R., and B.L.M.H. analyzed data;
and X.G., C.M.V., T.E.R., and B.L.M.H. wrote the paper.
The authors declare no conflict of interest.
Freely available online through the PNAS open access option.
Data deposition: The data reported in this paper have been deposited in the Gene
Expression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo (accession nos.
GSE46194, GSE44718, and GSE44809).
1To whom correspondence may be addressed. E-mail: tim.reddy@duke.edu or brigid.ho-
gan@duke.edu.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1307589110/-/DCSupplemental.
9356–9361 | PNAS | June 4, 2013 | vol. 110 | no. 23 www.pnas.org/cgi/doi/10.1073/pnas.1307589110
have very few intercellular junctions containing TJP1 (ZO-1).
The cells robustly express nuclear GRHL2, but have low levels
of GRHL1 and no detectable GRHL3. By contrast, when trans-
ferred to air–liquid interface (ALI) culture in differentiation me-
dium, the cells differentiate into a mucociliary epithelium in about
4 wk. In the initial 3–7 d after seeding, most cells are still un-
differentiated and express p63, KRT5, and GRHL2, with lower
levels of GRHL1 (Fig. 1F, Top). When confluent, the cells now
express obvious intercellular junctions with TJP1 and Claudin
4 (CLDN4) (see Fig. 3B). By ALI day (D) 10, p63− nuclei are
seen above the p63+ basal layer and GRHL1 is present at higher
levels in these suprabasal nuclei (Fig. 1F, Middle). Only by ALI
D35, when differentiated ciliated and secretory cells are present,
is GRHL3 detectable in ciliated cells (Fig. 1F, Bottom).
GRHL2 Regulates the Expression of Multiple Genes in Undifferentiated
HBE Cells.We used RNA-seq to identify genes regulated by GRHL2
in undifferentiated HBE cells from three human donors (Fig. 2A).
Specifically, we identified transcripts differentially expressed 24 h
after inhibiting GRHL function with an inducible lentivirus driving
a dominant-negative (DN) mutant form of the protein (Fig. S1).
This DN-GRHL2 protein, in which the N-terminal transactivating
domain is replaced with EGFP, is identical to a mouse DN-GRHL2
mutant protein previously shown to displace GRHL2 from a
known target site in the Cdh1 gene and to block its transcription
(9). Control virus expressed nuclear H2B-GFP.
There were 980 unique genes differentially expressed in the
DN-GRHL2 vs. control cells with an adjusted P value <0.05 and
an average change in expression greater than 50% (Dataset S1).
A similar proportion of genes was up- (n = 523) and down-
regulated (n = 457) (Fig. 2B). Annotating the differentially ex-
pressed genes with the Gene Ontology suggests that GRHL2
regulates diverse functions in undifferentiated HBE cells, in-
cluding those associated with morphogenesis, adhesion, and
migration. In addition, GRHL2-regulated proteins were signif-
icantly more likely to be localized to the cell periphery, espe-
cially the apical and apicolateral membranes (P = 7.5 × 10−3 and
P = 6.9 × 10−3, respectively). Full Gene Ontology enrichments
are shown in Dataset S2.
Some genes differentially expressed in response to DN-GRHL2
may lie downstream of direct targets, including microRNAs (19).
Therefore, to identify direct GRHL2 targets, we performed ChIP-
seq on HBE cells grown under the same conditions as for the
RNA-seq studies. There were 7,687 GRHL2 binding sites re-
producibly identified among all the three donors (Dataset S3).
The sites were enriched for the known GRHL2-binding motif
(Fig. 2C) and included the few genes that had been shown from
previous ChIP studies to have GRHL2 binding sites [e.g., CLDN4
and CDH1 (9, 16)]. Representative sites for MPZL2, KRT5,
SEMA4B, and HMBB1 are shown in Fig. 2E. Functional annota-
tion analysis of all genes near GRHL2 binding sites using
GREAT (20) reveals a specific enrichment for binding near genes
involved both in epithelial cell–cell adhesion [false discovery rate
(FDR), 5.2 × 10−8] and in cell–matrix adhesion [false discovery
rate, 9.7 × 10−4].
Genes that were differentially expressed with DN-GRHL2
were enriched for nearby GRHL2 binding, particularly within
40 kb of the transcription start site (Fig. 2D and Fig. S2A),
suggesting that those genes are direct targets of GRHL2. Based
on this analysis, we considered genes that are both regulated by
DN-GRHL2 and bound by GRHL2 within 40 kb of the tran-
scription start site to be direct targets (n = 296). These genes
were significantly more likely to have reduced expression after
DN-GRHL2 (206 vs. 90; P = 7 × 10−29 using a two-sided Fisher’s
exact test). More generally, the proportion of genes with reduced
expression after DN-GRHL2 directly and significantly correlated
with the proximity of GRHL2 binding to the transcription start
site (Spearman’s ρ = 0.09, P < 1 × 10−57; Fig. S2 B and C).
Clearly, there are many more GRHL2 binding sites in the
genome than genes modulated over 24 h in undifferentiated HBE
cells in response to DN-GRHL2. Therefore, to better understand
the specific function of candidate direct targets, we repeated the
functional enrichment analysis using only differentially expressed
genes with GRHL2 binding within 40 kb of the transcription start
Fig. 1. GRHL proteins in human airway cells. (A–C′) IHC of small and large
human airways (1- and 6-mm diameter, respectively) for GRHL1, 2, and 3
(red), p63 (green), and DAPI (blue). (D and E ) Small airways showing GRHL1
and 3 (red), E-cadherin (CDH1) (green), α-tubulin, a ciliated cell marker
(white), MUC5AC, a marker for goblet cells (white), and DAPI (blue). Single
images are from confocal stacks. (F ) IHC for GRHL1, 2, and 3 and airway
cell-specific markers of sections of HBE cultures at ALI D3, D10, and D35.
(Scale bars, 50 μm.)
Fig. 2. ChIP-seq and RNA-seq experiments. (A) Schematic for growing,
infecting, and harvesting primary HBE cells. (B) Relative expression of the
980 genes (rows) differentially expressed in response to DN-GRHL2. Log-
transformed expression levels were normalized on a per-gene basis. (C) The
GRHL2-binding motif identified in our GRHL2 ChIP-seq using de novo motif
discovery. (D) The fraction of genes with GRHL2 binding (y axis) within the
indicated distance of the transcription start site (TSS) (x axis). The orange and
black lines are differentially and not differentially expressed genes, re-
spectively, at the indicated FDR. (E) Examples of GRHL2 binding sites found
near GRHL2-regulated genes.








site (Dataset S4). These genes were specifically enriched in
multiple functional categories. Examples include those related to
multicellular organismal development (morphogenesis) (SEMA4A/B,
CTNNBIP1, GJB5, TGM1, MPZL2, COL7A1, OVOL2, and
GPR56 were among those down-regulated by DN-GRHL2),
hemidesmosome assembly (LAMA3 and KRT5), and cell “mo-
tility” (VEGFA, EPHA1, HMGB1, SUN2, NRP2, and PDGFA
were down-regulated and KDR and PRKD2 were up-regulated).
The last category includes genes that are likely involved in epi-
thelial-to-mesenchymal signaling (KDR, VEGFA, HMGB1,
and PDGFA).
GRHL2 Is Required to Establish Barrier Function and Differentiation of
HBE Cells in ALI Culture. After transfer to ALI culture, undif-
ferentiated HBE cells give rise to a well-differentiated, polarized
mucociliary epithelium with transepithelial resistance (TER). To
evaluate the role of GRHL2 in the formation of this epithelium,
we used the doxycycline (Dox)-inducible DN-GRHL2 lentivirus
system to inhibit protein function from the time the cells first
reach confluence (around ALI D7) (Fig. 3A). At this time, the
cultures have distinct apical junctional complexes and localized
CDH1, CLDN4, and TJP1 (Fig. 3B). In the experiment shown in
Fig. 3C, TER began to increase in control cultures at D11 and
reached a plateau around D18. However, following induction of
DN-GRHL2, the cultures completely failed to establish TER
(Fig. 3C). By ALI D14, although the number and density of cells
on the membranes were essentially the same, cells expressing
DN-GRHL2 (visualized by GFP staining) expressed much lower
levels of CDH1, CLDN4, and TJP1 than controls (Fig. 3D).
Significantly, CDH1 and TJP1 proteins had a more punctate
distribution. In the case of TJP1, the protein was often localized
in the nucleus, suggesting that inhibition of GRHL function
interferes with the shuttling of TJP1 between the nucleus and
cell membrane (21).
To confirm the specificity of the effect of DN-GRHL2 on
HBE cells in ALI culture, we used the same lentiviral protocol to
induce expression of an shRNA against GRHL2, with red
fluorescent protein (RFP) as a reporter. Control Western blot
and quantitative (q)PCR experiments at ALI D28 established
that this shRNA reduced protein and RNA levels by 64% and
75%, respectively, compared with scrambled shRNA (Fig. 4A).
Even though inhibition of GRHL2 protein levels was not com-
plete, Fig. 4B shows that GRHL2 shRNA inhibited the devel-
opment of TER compared with control RNA, with a statistically
significant difference in levels at ALI D21/22. Moreover, RFP+
cells within the cultures that express GRHL2 shRNA do not
differentiate into ciliated or secretory cells at ALI D28 (Fig. 4B).
Taken together, these results are further evidence that GRHL2
is required for the de novo establishment of barrier function and
the differentiation of primary HBE cells.
Returning to the experiments using DN-GRHL2, we used
Affymetrix microarray analysis to identify transcriptional
changes induced by inhibiting GRHL2 function between ALI D7
and D14 (Dataset S5). We found 607 unique genes that had a
significant change in expression between cells expressing
DN-GRHL2 versus EGFP (P < 0.05; absolute fold change in ex-
pression >1.5). Of those, 258 (43%) had lower expression,
whereas 349 (57%) had increased expression. The changes were
highly concordant with the results of DN-GRHL2 expression in
undifferentiated HBE cells, with 72% of genes regulated in the
same direction. Of the 61 genes with significant differential ex-
pression in both experiments, 92% were regulated in the same
direction. Genes with lower expression after DN-GRHL2 during
ALI D7–14 were strongly enriched in the GRHL2 binding sites
that we documented in undifferentiated HBE cells, suggesting that
a subset of the same GRHL2 binding sites is functional in the ALI
D7–14 cells. Of the 258 down-regulated genes, 125 (48%) had
GRHL2 binding within 40 kb of the transcription start site. In
comparison, only 77 (22%) of the up-regulated genes had GRHL2
binding sites. As in the undifferentiated HBE cells, the relative
enrichment of genes with reduced expression after DN-GRHL2
was stronger for GRHL2 binding sites located closer to the tran-
scription start site. This further suggests that GRHL2 binding
primarily increases expression of nearby genes.
We used qPCR to confirm the down-regulation of some of the
most highly differentially expressed genes, as well as other genes
selected for their known involvement in epithelial functions and
for having occupied GRHL2 sites in HBE cells (Fig. 3D). These
included known targets of GRHL2 in other tissues (CLDN4 and
ARHGEF19), even though the relative decreases in these genes
in the microarray (∼1.4-fold) were just below the cutoff for in-
clusion in Dataset S5. The confirmed genes encode proteins that
fall into a number of different classes, including membrane-
associated proteins such as PROM2, RHBDL2 [a membrane-
associated protease up-regulated in epidermal cells undergoing
wound repair (22)], SMAGP [small trans-membrane and glyco-
sylated protein (23)], STYK1 [a novel membrane-associated ty-
rosine kinase (24)], and SCRIB [implicated in planar cell polarity
and epidermal wound repair (25)]. Another class encompasses
small GTPases and other adaptor proteins, including RAB25 [as-
sociated with the recycling of membrane proteins and in GRHL2
function (13)], RAP1A (a Ras-related protein active in cell lo-
comotion), and VAV1 [a Rho-GEF implicated in barrier func-
tion in colon epithelium (26)]. A third class includes proteins
connected with cell adhesion, including CGN, CGNL1, CTNND1,
MPZL2 [also known as epithelial V-like antigen (EVA1) and
Fig. 3. DN-GRHL2 in HBE cells impairs establishment of barrier function. (A)
Schematic of infection, selection, and expression of DN-GRHL2 and control
H2B-GFP using TRIPZ lentivirus induced in confluent cultures at ALI D7. (B)
Whole-mount IHC of cells at ALI D7 for junction proteins [CDH1, CLDN4, and
TJP1 (ZO-1)], GRHL2, and p63. All cells express GRHL2 and most are p63+. (C)
Dox was added after cells reached confluence at ALI D7. Controls received no
Dox. Values are averages and SEM of triplicate wells and the data are from
one of n = 3 biological replicates. (D) Whole-mount IHC of DN-GRHL2 cul-
tures with and without Dox at ALI D14 for junction proteins CDH1, CLDN4,
and TJP1 (red) and GFP (green). Note that many cells expressing DN-GRHL2
have nuclear TJP1. (E) qPCR verification of genes differentially expressed in
microarray analysis. Values are average and SEM of samples analyzed in
triplicate from two biological replicates. (Scale bars, 20 μm.)
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implicated in barrier formation between Sertoli cells (27) and as
a target of Grhl2 in mouse embryonic neurectoderm (17)], and
PVRL4 [poliovirus receptor-related 4, also known as nectin4,
required for adherens junction formation in skin (28)]. Finally,
we confirmed down-regulation of genes encoding ESRP1, an
epithelial spicing regulatory protein (29), and various transcrip-
tion factors and cofactors, including VGLL1 (30), WDR5B [a
protein closely related to WDR5, a core component of the
Trithorax histone methyltransferase complex that interacts with
GRHL3 in keratinocyte differentiation (10)], ZNF750 [associ-
ated with the differentiation and development of barrier function
of keratinocytes (31)], and ZNHIT6 [zinc finger protein impli-
cated in RNA processing and emphysema (32)].
As shown in Fig. 3D, qPCR also confirmed the differential
expression of transcripts for genes most highly up-regulated in
the array. All except IFIT1, IFI6, and IFI44L (which encode IFN-
inducible proteins) have occupied GRHL2 binding sites in basal
cells. They were CA2, KRT6B, NPR3 (natriuretic peptide receptor
3), SERPINE2 (a peptidase inhibitor), SMOC1 (SPARC-related
modular calcium binding 1), and STMN3 (also known as SCLIP,
encoding a member of a family of proteins that destabilizes
microtubules and promotes the motility of non-small-cell lung
cancer cells (33).
Finally, the qPCR analysis confirmed that there was no change
in the level of transcripts for the junction proteins CDH1 and
TJP1 (Fig. 3D), even though these genes have distinct GRHL2
binding by ChIP-seq analysis of basal cells and CDH1 has been
identified as a direct target in other cell types.
GRHL2 Is Required to Maintain Barrier Function in ALI Cultures. We
next asked whether GRHL2 is required to maintain the integrity
of the epithelium once barrier function has been established. To
achieve this, Dox was added to cells transfected with either DN-
GRHL2 or H2B-GFP virus at a time when TER values had
reached a maximum (Fig. 5A). In the experiment shown in Fig.
5B, TER starts to decline 48 h after adding Dox and 7–10 d later
reaches a new lower baseline. At this time, control cultures have
a cobblestone epithelial appearance (Fig. 5C). By contrast, cells
expressing DN-GRHL2, although still confluent, appear more
extended and less closely adherent to each other. This difference
in morphology is reflected in histological sections of the coherent
epithelial layer (Fig. 5D). There was no evidence for significant
cell death (by staining for cleaved caspase 3) or for a difference
in proliferation (Ki67 staining, Fig. 5E) between control and
experimental cultures.
To identify GRHL-regulated genes, we treated ALI cultures
transfected with either H2B-GFP or DN-GRHL2 virus with Dox
when the TER reached a threshold level (between ALI D14 and
D18, depending on the donor). RNA was isolated from cultures
harvested just 48 h later to focus on early events in the uncou-
pling of junctional interactions, including those regulating TER.
We found 94 unique genes expressed at lower levels and 209
expressed at higher levels in cells expressing DN-GRHL2 com-
pared with control (P < 0.05; absolute fold change >1.5; Dataset
S6). Again, genes expressed at lower levels were much more
likely to have previously identified GRHL2 binding sites close to
the transcription start site than genes expressed at higher levels
(65% vs. 19% for GRHL2 binding within 40 kb). Genes with
significant differential expression after DN-GRHL2 expression
during ALI D7–14 and ALI D14–18 were highly concordant
between the two experiments (Spearman’s ρ = 0.88). For no genes
reaching our significance criteria did the expression level after
DN-GRHL2 expression change in opposite directions. qPCR
was used to confirm the down-regulation of the same set of genes
down-regulated in cultures treated with Dox at ALI D7 (Fig. 5F).
Fig. 4. GRHL2 shRNA inhibits barrier formation and differentiation of HBE
cells. The protocol for induction of GRHL2 shRNA and control scrambled RNA
was as for Fig 3. (A) (Left) Western blot of extracts of ALI cultures treated
with Dox between D7 and D28 shows that GRHL2 shRNA reduced protein
levels by 64% compared with control shRNA. ACTB, β-actin loading control.
(Right) qPCR shows a corresponding 75% reduction of GRHL2 transcript
levels. Values are average and SEM of triplicates. (B) Values for TER are
averages and SEM of triplicate wells and data are from one of n = 2 bi-
ological replicates. (C) At ALI D28, cultures were stained in whole-mount for
α-tubulin, MUC5AC, and DAPI. RFP-positive cells express shRNA. Cells that
express GRHL2 shRNA do not differentiate. (Scale bars, 50 μm.)
Fig. 5. DN-GRHL2 disrupts established barrier function in HBE cells. (A)
Schematic of infection, selection, and induction of DN-GRHL2 when cultures
had attained their high electrical resistance. (B) After induction of DN-GRHL2
at ALI D13, the TER of HBE cultures decreased compared with controls
without induction or with H2B-GFP (not shown). Samples analyzed as in Fig.
3B. (C and D) Bright-field images and hematoxylin and eosin-stained sections
of control H2B-GFP and DN-GRHL2–expressing cells on inserts at ALI D21. (E)
Whole-mount IHC of control H2B-GFP and DN-GRHL2 cultures using Ki67
showed no difference in cell proliferation. (F) qPCR verification of genes
differentially expressed in microarray analysis. Values as in Fig. 3E from n = 3
biological samples. (Scale bars, 10 μm.)








Finally, we identified genes specifically regulated by DN-GRHL2
in undifferentiated HBE cells compared with cells that are
both establishing and maintaining transepithelial resistance
in ALI culture. The analysis confirmed that only a small frac-
tion of genes was specifically regulated by DN-GRHL2 be-
tween progenitor cells and cells in ALI culture (Fig. S2D and
Dataset S7).
Discussion
Taken together, our studies provide compelling evidence that
GRHL transcription factors and their downstream targets play
important roles in the mucociliary epithelium of the human lung.
In particular, the ChIP-seq studies unequivocally establish in an
epithelial cell type that GRHL2 binds near thousands of genes
encoding proteins involved in multiple cellular processes, many
of which are common to epithelial cells in general. It appears
that GRHL2 most frequently functions in HBE cells to positively
regulate gene transcription. There is also evidence that it directly
or indirectly has a role in transcriptional repression. In addition,
GRHL2 may function as a “placeholder,” helping to keep a
subset of unexpressed genes poised for the later assembly of
additional regulatory factors in cell types derived from the basal
cells. Further experiments are necessary to distinguish between
these possibilities.
A central strategy of this study was to identify genes regulated
by GRHL2 in primary HBE cells at different stages of differ-
entiation, in basal progenitors, or in cells in ALI culture estab-
lishing barrier function and differentiating into ciliated and
secretory cells. At each stage it appears that expression of
DN-GRHL2 leads to the down- or up-regulation of several
hundreds of genes. Not all potential direct targets are affected,
for at least two potential reasons. First, DN-GRHL2 may not be
fully effective in occupying GRHL2 sites, or in displacing wild-type
protein that is tightly bound. Second, even when the mutant protein
is present and bound, other factors associated with particular
genes may compensate for the lack of GRHL2 transactivation
function. Nevertheless, it appears that GRHL2 does regulate
a large set of genes common to all three stages of differentiation,
in particular those related to epithelial morphogenesis, adhesion,
and locomotion. The precise in vivo function of most of these
genes remains to be determined. There is experimental evidence
that several of them (e.g., MPZL2, PVRL4, RHBDL2, VAV1,
and ZNF750) play a role in epithelial barrier function, wound
repair, and pathology in other tissues. This suggests that we have
uncovered a set of genes that could potentially mediate impor-
tant functions relevant to airway health and disease. One strategy
to define these functions will be to conditionally manipulate
them in the mouse trachea, a model for the human mucociliary
epithelium with basal cells (1).
Finally, our data provide evidence for considerable complexity
in the mechanisms by which GRHL2 regulates functions such as
intercellular adhesion in HBE cells. For example, inhibiting
GRHL2 function in cells between ALI D7 and D14 leads to the
absence of the discrete localization of TJP1 protein in apical
junctional complexes. However, TJP1 protein is still present in
the cells, albeit in a punctate pattern in the cytoplasm and nu-
cleus. GRHL2 binds to the promoter region of TJP1, but there is
apparently no change in RNA levels in response to DN-GRHL2.
This suggests that other genes that are directly regulated by
GRHL2 indirectly affect processes such as junction assembly and
cell polarity at the posttranscriptional or posttranslational level.
Potential mechanisms include alternative splicing of transcripts
by ESRP1/2 [epithelial splicing regulatory proteins (29)], traf-
ficking of membrane components through RABs, and dynamic
interaction of membrane proteins with the cytoskeleton medi-
ated by multiple ARHGEF and ARHGAP family members.
Defining the precise hierarchy of mechanisms by which GRHL2
affects epithelial behavior and how these intersect with other
regulatory networks will require multiple lines of investigation.
Materials and Methods
Cell Culture. Primary HBE cells were obtained from donors without pre-
existing lung disease under University of North Carolina at Chapel Hill
Biomedical IRB protocol #03-1396. ChIP-seq and RNA-seq experiments
used the same three donors. Passage (P) 1 P1 cells were seeded into
plastic dishes coated with bovine collagen (Advanced BioMatrix; Pure-
Col, 5005-B) in BEGM Basal Epithelial Growth Medium (34) containing
0.11 mM Ca2+ and 25 ng/mL EGF (34). Confluent cultures were passaged
to P2 in dishes without collagen. For ChIP-seq, P2 cells were collected at
confluence. For RNA-seq, P2 cells at 40% confluence were infected with
H2B-GFP or DN-GRHL2 lentivirus and 1 μg/mL puromycin was added 48 h
later. At confluence, 0.5 μg/mL Dox was added for 24 h.
For ALI cultures, P0 HBE cells were seeded in collagen-coated 10-cm dishes.
At 40% confluence, cultures were infected with lentivirus and grown for 48 h
before puromycin selection. At 70–90% confluence, 1.25 × 105 cells were
seeded onto collagen IV (Sigma-Aldrich; C7521)-coated 12-mm Transwell
permeable supports (Corning; 3460) in ALI culture medium (formula is given
in ref. 34) with 1 mM Ca2+ and 0.5 ng/mL EGF. Medium was changed three
times a week. Triplicate inserts were washed and 500 μL ALI medium was
added before measuring TER every other day using a Millicell ERS2 (Milli-
pore). The value was calculated in ohms per cm2 and the resistance of the
membrane inserts only was subtracted. The unit area resistance is obtained
by multiplying the electric resistance by the effective surface area of
the filter.
Lentivirus. An shRNA targeting hGRHL2 (V2THS_176822) and a nonsilencing
control shRNA (RHS4743) were from Thermo Scientific. To construct a Tet-on
GFP-labeled dominant-negative mutant of GRHL2, DNA encoding a trun-
cated version of mouse GRHL2 in which amino acids 1–232 were replaced
with EGFP or H2B-GFP was cloned into pTRIPZ inducible lentiviral vector
(Thermo Scientific) between AgeI and MluI. The vector was modified to
replace RFP and insert bovine growth hormone polyA sequence after the
truncated GRHL2 for its expression. Plasmids were transfected into 293T
cells as described (35) using FuGENE 6 (Promega, E2691). Viral expression was
confirmed by visualizing GFP after adding Dox.
Grhl3 Antibody. Rabbit polyclonal Grhl3 antibody was produced by Harlan
Bioproducts for Science against amino acids 75–230 of mouse Grhl3 (83%
identical to human protein). GST-Grhl3 was used for primary immunization
and His-Grhl3 for boosting. The antibody was affinity-purified using His-Grhl3
and specificity was confirmed by IHC in the presence of blocking peptide.
Immunohistochemistry. Normal human lungs and ALI cultures were fixed in
4% (wt/vol) paraformaldehyde (PFA) at 4 °C for 3 h and overnight, re-
spectively. Samples were embedded in paraffin, sectioned at 7 μm, and
stained as described (36). For whole-mount staining of ALI cultures, mem-
branes were washed with PBS and fixed with 4% PFA for 10 min at room
temperature. Antibodies were rabbit GRHL1 (1:100; Sigma; HPA006420),
rabbit GRHL2 (1:450; Sigma; HPA004820), rabbit Grhl3 (1:2,000), mouse
monoclonal P63 (1:50; Santa Cruz; sc-8431), rabbit TJP1 (1:100; Invitrogen;
61-7300), mouse monoclonal MUC5A (1:200; Lab Vision; MS145-PO), rat
CDH1 (1:500; Zymed; 13-1900), mouse acetylated tubulin (1:1,000; Sigma; T-
7451), chicken GFP (1:500; Aves Labs; 1020), rabbit anti-Claudin4 (1:150;
Invitrogen; 36-4800), mouse Ki67 (1:100; Vector Labs; VP-K452), and rab-
bit cleaved caspase 3 (1:600; Cell Signaling; 9664). Antigen retrieval on
paraffin sections used 100 mM sodium citrate butter (pH 6) in a pressure
cooker-like device (PickCell Laboratories; 2100 Retriever).
RNA-Seq. We performed RNA-seq on untreated, control-infected, and DN-
GRHL2–infected HBE cells as described (37). For details and accession num-
bers, see SI Materials and Methods. We estimated differential expression
using DESeq (38) to compare a model that included donor and condition
(untreated, control-infected, or DN-infected) with a model that only
accounted for donor. To be called differentially expressed, genes were
required to have an FDR less than 0.05 and a more than 50% change in
expression between control and DN-GRHL–infected cells. Genes were
analyzed for enriched categories from Gene Ontology as described (39).
ChIP-Seq. ChIP-seq for GRHL2 was performed on HBE cells from three donors
as described (40, 41) (see also SI Materials and Methods; Gene Expression
Omnibus accession no. GSE46194). To control for sonication biases, we se-
quenced a matched input control library made from sonicated chromatin
from each donor. We identified binding sites relative to the donor-specific
input control using MACS (42). To identify reproducible GRHL2 binding sites
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for our final analyses, we calculated pairwise irreproducibility discovery rates
(IDRs) (43, 44) and retained binding sites with an IDR of >0.05 in all three
comparisons.
Integrative ChIP-Seq and RNA-Seq Analysis. To identify genes most likely to be
directly regulated by GRHL2, we identified the GRHL2 binding site nearest
each RefSeq gene (42). To determine a characteristic binding distance for
functional GRHL2 binding, we plotted the cumulative distribution of the
distance to the nearest GRHL2 binding site for genes with increasingly
significant differential expression as determined by RNA-seq. We observed
a strong enrichment for GRHL2 binding within 40 kb of genes with a highly
significant response to the GRHL knockdown (Fig. S2A). Based on this analysis,
we considered differentially expressed genes within 40 kb of a GRHL2 binding
site to be likely direct GRHL2 targets. To determine functional enrichment in
likely direct GRHL2 target genes, we analyzed the genes for enriched cate-
gories from Gene Ontology (45) using the GOStats package (46).
Statistical Analysis of RNA-Seq and ChIP-Seq. Statistical analysis for RNA-seq
and the integrative analysis with the GRHL2 ChIP-seq were performed using
the R statistical package (http://www.r-project.org); a script to reproduce
that analysis is available upon request. All alignment, ChIP-seq peak
calling, and ChIP-seq replicate analysis were performed using publicly
available software (SI Materials and Methods).
Microarray Analysis. RNA was extracted using an RNeasy Micro Kit (QIAGEN)
and quality-checkedwith a 2100 Bioanalyzer (Agilent Technologies). RNAwas
processed using Ambion MessageAmp Premier by the Duke Microarray Fa-
cility. Standard Affymetrix protocols and human genome U133 Plus 2.0 chips
were used to generate .cel files. Genomics Suite 6.5 (Partek) was used
to perform data analysis. Robust multichip analysis normalization was
performed on each dataset. Two-way ANOVA and fold-change analyses
were performed to select target genes that were differentially expressed
between control and DN-GRHL2 datasets. The top differentially expressed
genes were selected with a P-value cutoff of <0.05 based on ANOVA test and
a fold-change cutoff of >±1.5.
qRT-PCR. RNA was extracted with the RNeasy Micro Kit (QIAGEN) and cDNA
was synthesized with SuperScript III (Invitrogen). PCR was performed with
SYBR Green chemistry in a StepOnePlus Real-Time PCR System (Applied
Biosystems). Samples were analyzed in triplicate from two or three biological
replicates and data were analyzed using the ΔΔCt method (47). Primer
sequences are listed in Table S1.
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